Nuveen Missouri Quality Municipal Income Fund

Nuveen Missouri Quality Municipal Income Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of Missouri. The fund invests in undervalued municipal securities and other related investments the income from which is exempt from regular federal and Missouri income taxes. It seeks to invest in investment grade securities. The fund employs fundamental analysis with a focus on bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against Standard & Poor's (S&P) Missouri Municipal Bond Index and Standard & Poor's (S&P) National Municipal Bond Index. The fund was formerly known as Nuveen Missouri Premium Income Municipal Fund. Nuveen Missouri Quality Municipal Income Fund was formed on March 29, 1993 and is domiciled in the United States.

Nuveen Missouri Quality Municipal Income Fund trades as NOM on NYSE. The company is classified in Financial Services / Asset Management - Income and reports in USD.

The current profile places the business in Asset Management - Income. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $320,455 of revenue and -$716,072 of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Nuveen Missouri Quality Municipal Income Fund can be compared against peers such as Barrett Growth Fund, MFS Intermediate High Income Fund, CornerCap Small-Cap Value Fund, Shelton Emerging Markets Fund, Guinness Atkinson China & Hong Kong Fund, James Micro Cap Fund.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $25.88M, beta of 0.40, and return on equity of -2.9%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

NOM currently shows total debt of $0 and beta of 0.40. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: NPORT-P (2026-04-27 00:00:00), 25-NSE (2026-04-27 00:00:00), 4 (2026-03-27 00:00:00), SC 13D/A (2026-03-27 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.nuveen.com/CEF/Product/Overview.aspx?FundCode=NOM&refsrc=vu_nuveen.com/nom

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.